IRCM Activities
and Events

Filter

Events to come

thumbnail

Olivier Pourquié, PhD

Oct 03, 2022
From 11:30 AM to 12:30 PM

Montréal


IRCM Conference

thumbnail

IRCM Challenge

From Oct 08 to Oct 23 2022


Athletic Challenge

thumbnail

Damien Contandriopoulos

Oct 13, 2022
From 12 PM to 1 PM


Conference

thumbnail

Sekar Kathiresan, MD

Oct 17, 2022
From 11:30 AM to 12:30 PM

Montréal


Conference

thumbnail

Carl Wu, PhD

Oct 24, 2022
From 11:30 AM to 12:30 PM

Montréal


Conference

thumbnail

Geneviève Almouzni, PhD

Oct 31, 2022
From 11:30 AM to 12:30 PM

Montréal


Conference

thumbnail

Rashmi Kothary, PhD

Nov 07, 2022
From 11:30 AM to 12:30 PM

Montréal


Conference

thumbnail

Kathryn E. Wellen, PhD

Nov 14, 2022
From 11:30 AM to 12:30 PM

Montréal


Conference

thumbnail

Carmen Birchmeier-Kohler, PhD

Nov 21, 2022
From 11:30 AM to 12:30 PM

Montréal


Conference

thumbnail

Oscar Marín, PhD

Nov 28, 2022
From 11:30 AM to 12:30 PM

Montréal


Conference

thumbnail

Annual Dinner

Dec 01, 2022
Montréal


Dinner

thumbnail

Julie Segre, PhD

Dec 12, 2022
From 11:30 AM to 12:30 PM

Montréal


Conference

Évènements passés

Almudena R. Ramiro

Conference
Almudena R. Ramiro

Atherosclerosis antigens and antibodies: novel clinical opportunities?

Almudena R. Ramiro PhD
Full Professor
Spanish National Center for Cardiovascular Research
Madrid, Spain

This conference is organized by Javier Di Noia. It is part of the 2021-2022 IRCM conference calendar.

Zoom Link : https://zoom.us/j/95269762104
ID : 952 6976 2104
Code : 476372

About the conference:
Cardiovascular disease is the first cause of death in the world, with atherosclerosis being the underlying cause of the majority of cardiovascular events. Atherosclerosis has a strong immune component. However, our understanding on the antigens that trigger the atherosclerosis immune response is very limited. We have performed an unprecedented screening of atherosclerosis-associated antibodies (AAAbs) by single cell sequencing and expression of antibody genes. We identified 18 AAAbs that recognize the atherosclerotic plaque. We further uncovered that the specific antigen for one such AAAb, called A12, is the ALDH4A1 self-protein. Importantly, plasma levels of ALDH4A1 are increased in atherosclerotic mice and humans. Moreover, A12 infusion delays plaque progression in atherosclerotic mice. Thus, our work provides new candidates for the development of novel diagnostic and therapeutic strategies.

About Almudena R. Ramiro:
Dr. Almudena R. Ramiro is a professor at the Spanish National Center for Cardiovascular Research in Madrid, where she studies B-cell biology and antibody immune responses. Her latest work has focused on antigens and microRNAs that affect cardiovascular health. Dr. Ramiro’s research is funded by the Spanish Ministry of Science and Innovation and the “La Caixa” Foundation. She is the recipient of the 2021 Caja Rural de Granada Award for Health Sciences Research and has been actively involved since 2009 in the Biomedicine and the Fundamental Biology study sections of the Ministry. Dr. Ramiro has published in the most prestigious scientific journals, including Nature, Immunity, Blood, and Trends in Immunology.

To make sure you don't miss any of the IRCM conferences, sign up now for our newsletter!

Newsletter

Discoveries,
events and more

Subscribe

IRCM Foundation

Be part of the
solution

Support health research